c-Myc: an emerging participant in heart failure. [PDF]
Wu Y +11 more
europepmc +1 more source
Conformational reprogramming of c-Myc <i>via</i> intracellular cyclisation. [PDF]
Johnson RA, Mason JM.
europepmc +1 more source
Pinoresinol as a Potential c-Myc Complex Modulator: An In Silico Study. [PDF]
Villanueva-Castillo A +18 more
europepmc +1 more source
Crotonylation impedes c-Myc oncogenic activity. [PDF]
Wallbillich NJ +5 more
europepmc +1 more source
Triggering SORL1 Expression Restricts ccRCC Progression by Inducing Ubiquitination-Mediated c-Myc Degradation. [PDF]
Wang K +11 more
europepmc +1 more source
P38α deficiency alleviates myocardial ischemia/reperfusion injury by stabilizing c‑Myc to inhibit ferroptosis. [PDF]
Ouyang X +15 more
europepmc +1 more source
The NSDHL/c-Myc/PKM2 Axis Drives Glycolytic Reprogramming and Tumor Growth in Multiple Myeloma. [PDF]
Yue C, Huang BH, Qi L, Zhang XD, Li J.
europepmc +1 more source
Oncogene c‑Myc: From molecular mechanism to targeted therapy (Review). [PDF]
Lu J +7 more
europepmc +1 more source
Evaluation of c-Myc in odontogenic cysts and tumours-An immunohistochemical study. [PDF]
Pinisetti S +5 more
europepmc +1 more source
RFC5 and STAT3 form a transcriptional complex to drive NSCLC progression via c-Myc. [PDF]
Yan J +10 more
europepmc +1 more source

